[1]
Shazia Muneer et al. 2024. IMMUNOGLOBULIN-G SEROPREVALENCE AGAINST SARS-COV-2 AND ASSOCIATED RISK FACTORS IN LAHORE, PAKISTAN; A POPULATION-BASED SURVEY. Journal of Population Therapeutics and Clinical Pharmacology. 31, 2 (Feb. 2024), 2399–2408. DOI:https://doi.org/10.53555/jptcp.v31i2.4636.